Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Cellular Biomedicine Group, Inc. | Financial_Report.xls |
| 10-K - ANNUAL REPORT - Cellular Biomedicine Group, Inc. | ebig_10k.htm |
| EX-32.1 - CERTIFICATION - Cellular Biomedicine Group, Inc. | ebig_ex321.htm |
| EX-31.1 - CERTIFICATION - Cellular Biomedicine Group, Inc. | ebig_ex311.htm |
| EX-31.2 - CERTIFICATION - Cellular Biomedicine Group, Inc. | ebig_ex312.htm |
| EX-23.1 - CONSENT - Cellular Biomedicine Group, Inc. | ebig_ex231.htm |
Exhibit 32.2
CERTIFICATIONS OF CHIEF FINANCIAL OFFICER
I, Norm Klein, certify, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report on Form 10-K of EastBridge Investment Group Corporation for the fiscal year ended December 31, 2011 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in this Annual Report on Form 10-K fairly presents in all material respects the financial condition and results of operations of EastBridge Investment Group Corporation.
|
By:
|
/s/ Norm Klein
|
|
|
Date: March 30, 2012
|
Name:
|
Norm Klein
|
|
Title:
|
Chief Financial Officer
|
|
|
(Principal Financial Officer)
|